FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Peron, Priscila Ferrari; Wehrbein, Heinrich; Mundethu, Ambili et al.
Clinical parameters and inflammatory biomarkers among patients with multibracket appliances: a prospective clinical trialBMC ORAL HEALTH. Bd. 24. H. 1. 2024
Gioia, Guglielmo; Kresoja, Karl-Patrik; Rosch, Sebastian et al.
Clinical Trajectory and Risk Stratification for Heart Failure with Preserved Ejection Fraction in a Real-World Cohort of Patients with Suspected Coronary Artery DiseaseJOURNAL OF CLINICAL MEDICINE. Bd. 13. H. 7. 2024
Freedman, Mark S.; Ziemssen, Tjalf; Bar-Or, Amit et al.
Clinical Validation of a Novel In Vitro Diagnostic Neurofilament Light Chain Assay for the Prognostication of Disease Activity in People with Relapsing Multiple SclerosisMULTIPLE SCLEROSIS JOURNAL. Bd. 30. H. 3. 2024 S. 1238-1239
Winter, Susann; Goetze, Katharina S.; Hecker, Judith S. et al.
Clonal hematopoiesis and its impact on the aging osteo-hematopoietic nicheLEUKEMIA. Bd. 38. H. 5. 2024 S. 936-946
Doerr, Fabian; Stange, Sebastian; Salamon, Sophie et al.
Closing the RCT Gap-A Large Meta-Analysis on the Role of Surgery in Stage I-III Small Cell Lung Cancer PatientsCANCERS. Bd. 16. H. 11. 2024
Schunke, Jenny; Hueppe, Natkritta; Mangazeev, Nicole et al.
Co-delivery of STING and TLR7/8 agonists in antigen-based nanocapsules to dendritic cells enhances CD8+T cell-mediated melanoma remissionNANO TODAY. Bd. 57. 2024
Cali, Bianca; Troiani, Martina; Bressan, Silvia et al.
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancerCANCER CELL. Bd. 42. H. 10. 2024
Heinemann, Markus K.
Coal HolesTHORACIC AND CARDIOVASCULAR SURGEON. Bd. 72. H. 08. 2024 S. 577-578
Muenzel, Thomas; Hahad, Omar; Daiber, Andreas
Coding Hypertension by Nicotine: Unraveling the Sex-Specific Role Of m6A Demethylase for NOX2 RNA-Protein ConnectionHYPERTENSION. Bd. 81. H. 2. 2024 S. 252-254
Boesl, Fabian; Goereci, Yasemin; Schweitzer, Finja et al.
Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damageSCIENTIFIC REPORTS. Bd. 14. H. 1. 2024